BREAKING: The most controversial article of the year, claiming that early morning immunotherapy works better than in the afternoon, is now retracted.
After reading the responses provided by the authors to the inconsistencies raised in the web, the @NatureMedicine editors no longer have confidence in the integrity of the results. The only prospective evidence that time-of-day matters for immunotherapy is now gone.
https://t.co/aXUY6aekhl
To me, this means (at least) two things.
First, it confirms that prudence on this topic was and remains critical. For as inexpensive it may be to give a drug earlier or later in the day, it carries a much more relevant cost: the one of scientific integrity. We owe our patients to make decisions based on solid data. We should not give up this practice too easily, particularly in the presence of several concerning red flags.
Second, this retraction should also prompt a broader reflection on the current state of peer review, in which unpaid reviewers struggle to keep up with a steady rise in submitted papers. Journals need to improve the process by implementing a formal, consistent, in-depth review of each paper by paid professionals. A practice that, in this case, may have avoided a retraction arriving after 22 citations and after inclusion of this study in at least one meta-analysis. And possibly, after some physicians had already changed their practice in IO administration.
For a thoughtful recap of this story, I recommend this well-written new piece in @ScienceMagazine by Laura Agudelo. I’m grateful to Laura for including my perspective in the article.
https://t.co/qHM5fMjwQ3
Repeated concussions can change the brain over time.
New research from MUSC shows that immune activity may play a major role in long term damage after mild traumatic brain injuries.
Find out more: https://t.co/FvAD24Z7FG
#ChangingWhatsPossible
(2/2) Also, none of this work could have been possible without Dr. Silvia Guglietta (@GugliettaLab), Dr. Stephen Tomlinson, and all the contributing authors. @MUSChealth
🔥📢BIG NEWS!
(1/2) I'm excited to share our accepted paper in Nature's Signal Transduction and Targeted Therapy (@sigtrans_sttt) showing a role for complement in repetitive closed head injury. Many thanks to @ResearchMUSC@DeptVetAffairs@NIH@biaamerica
https://t.co/yFIWILpion
🚨Our team @GugliettaLab@KhalilMallahPhD just published in Signal Transduction & Targeted Therapy: 10.1038/s41392-025-02466-7. Repetitive mild head injury activates brain’s complement system—driving inflammation&memory loss. Complement blockage protects. @MedUnivSC@ResearchMUSC
We performed a multi-omic characterization of the immune landscape in our new model of repetitive traumatic brain injury and identified the mechanisms associated with the protective role of complement inhibition. Great teamwork @GugliettaLab@KhalilMallahPhD@CarstenKriegPhD
Happy to share that our article on the role of the complement system in intestinal inflammation and colon cancer is now published in @jclinicalinvest. Great team work @CarstenKriegPhD and @GugliettaLab
The complement system in intestinal inflammation and cancer
As part of JCI’s Review series on complement biology and therapeutics, Carsten Krieg & Silvia Guglietta @GugliettaLab@MedUnivSC et al. highlight the complement system in the GI tract under homeostasis, #inflammation, and during tumor development, progression, and treatment: https://t.co/Kks9gOOMhP
This week on Health Focus, Hollings researcher Dr. Silvia Guglietta talks about her work on immunotherapy in colon cancer. Listen on your SC Public Radio station, or check out the website! https://t.co/y5XWeTeT1n
Cool work from @IlievLab and collaborators: Fungal symbiont transmitted by free-living mice promotes type 2 immunity | Nature https://t.co/uATs5sEGxR
Have you applied for your IMMUNOLOGY2025™️ travel award? Boost your professional development in May! Whether you're with a Laboratory, #Undergrad, #EarlyCareer - apply today: https://t.co/VMuSxf4fJ2. #AAI2025#IMMUNOLOGY2025
Complement factor H is an ICOS ligand modulating Tregs in the glioma microenvironment | Cancer Immunology Research | American Association for Cancer Research https://t.co/UqKbWRmQIk